Antibodies against fibrin degradation products, reagents and kits for detecting fibrin degradation products
By developing specific anti-fibrin degradation product antibodies, the problem of difficulty in effectively detecting fibrin degradation products in the prior art is solved, and high sensitivity and specificity detection effects are achieved, providing an effective tool for diagnosis and disease monitoring.
CN118240086BActive Publication Date: 2025-05-09DONGGUAN PENGZHI BIOTECH CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202311265501.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2022-10-08
- Filing Date
- 2023-09-27
- Publication Date
- 2025-05-09
- Estimated Expiration
- 2043-09-27
AI Technical Summary
Technical Problem
The prior art has difficulty in effectively binding fibrin degradation products (FDPs) and testing, resulting in difficulties in diagnosis and disease monitoring.
Method used
An antibody against fibrin degradation products is developed, which includes specific heavy and light chain variable region amino acid sequences that are capable of efficiently binding to FDPs for reagents and kits for detecting fibrin degradation products.
Benefits of technology
By using these antibodies, detection sensitivity and specificity of fibrin degradation products can be significantly improved, providing an effective tool for diagnosis and disease monitoring.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure CN118240086B_ABST
Abstract
The present invention discloses an anti-fibrin degradation product antibody, a reagent and a kit for detecting fibrin degradation products, and relates to the field of antibodies. The anti-fibrin degradation product antibody disclosed in the present invention comprises a heavy chain complementary determining region and a light chain complementary determining region, and the antibody provides an important source of raw materials for the detection of fibrin degradation products and has good affinity or activity.
Need to check novelty before this filing date? Find Prior Art